LSBCF (LakeShore Biopharma Co) Tax Expense: $-0.13 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Tax Expense?

LakeShore Biopharma Co LSBCF Tax Expense is $-0.13 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

LakeShore Biopharma Co's tax expense for the months ended in Mar. 2025 was $-0.30 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.13 Mil.

LakeShore Biopharma Co  (OTCPK:LSBCF) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.

LakeShore Biopharma Co Tax Expense Related Terms

LakeShore Biopharma Co Tax Expense Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Tax Expense Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Tax Expense
2.68 0.78 0.17 -3.02 -0.13

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Tax Expense Get a 7-Day Free Trial Premium Member Only 0.08 -0.11 -2.90 0.17 -0.30

LakeShore Biopharma Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of $-0.13 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Tax Expense of $-0.13 Mil as of Mar. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Tax Expense too high?
LakeShore Biopharma Co's current Tax Expense is $-0.13 Mil.
How does LakeShore Biopharma Co's Tax Expense compare to ACUT and PPCB?
LakeShore Biopharma Co's Tax Expense of $-0.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Biotechnology company?
A good Tax Expense depends on the Biotechnology industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Tax Expense is $-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Tax Expense of $-0.13 Mil. The current Tax Expense is $-0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Tax Expense is $-0.13 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.